# Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer

> **NCT05401175** · NA · RECRUITING · sponsor: **Chongqing University Cancer Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **OTHER:** Autologous blood transfusion with haematopoietic stem cells

## Key facts

- **NCT ID:** NCT05401175
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-13
- **Primary completion:** 2025-04
- **Final completion:** 2027-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401175, "Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05401175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*